BLUE
Price
$4.97
Change
-$0.00 (-0.00%)
Updated
May 30 closing price
Capitalization
48.67M
BVAXF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
8.59M
Interact to see
Advertisement

BLUE vs BVAXF

Header iconBLUE vs BVAXF Comparison
Open Charts BLUE vs BVAXFBanner chart's image
bluebird bio
Price$4.97
Change-$0.00 (-0.00%)
Volume$1.25M
Capitalization48.67M
BioVaxys Technology
Price$0.03
Change-$0.00 (-0.00%)
Volume$40.84K
Capitalization8.59M
BLUE vs BVAXF Comparison Chart
Loading...
BLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLUE vs. BVAXF commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLUE is a StrongBuy and BVAXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (BLUE: $4.98 vs. BVAXF: $0.03)
Brand notoriety: BLUE and BVAXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLUE: 132% vs. BVAXF: 42%
Market capitalization -- BLUE: $48.67M vs. BVAXF: $8.5M
BLUE [@Biotechnology] is valued at $48.67M. BVAXF’s [@Biotechnology] market capitalization is $8.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLUE’s FA Score shows that 1 FA rating(s) are green whileBVAXF’s FA Score has 0 green FA rating(s).

  • BLUE’s FA Score: 1 green, 4 red.
  • BVAXF’s FA Score: 0 green, 5 red.
According to our system of comparison, BLUE is a better buy in the long-term than BVAXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLUE’s TA Score shows that 6 TA indicator(s) are bullish.

  • BLUE’s TA Score: 6 bullish, 4 bearish.

Price Growth

BLUE (@Biotechnology) experienced а +0.20% price change this week, while BVAXF (@Biotechnology) price change was +3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLUE($48.7M) has a higher market cap than BVAXF($8.59M). BVAXF YTD gains are higher at: -23.877 vs. BLUE (-40.288). BVAXF has higher annual earnings (EBITDA): -4.13M vs. BLUE (-215.81M). BLUE has more cash in the bank: 70.7M vs. BVAXF (157K). BVAXF has less debt than BLUE: BVAXF (67.7K) vs BLUE (368M). BLUE has higher revenues than BVAXF: BLUE (53.1M) vs BVAXF (0).
BLUEBVAXFBLUE / BVAXF
Capitalization48.7M8.59M567%
EBITDA-215.81M-4.13M5,225%
Gain YTD-40.288-23.877169%
P/E RatioN/AN/A-
Revenue53.1M0-
Total Cash70.7M157K45,032%
Total Debt368M67.7K543,575%
FUNDAMENTALS RATINGS
BLUE vs BVAXF: Fundamental Ratings
BLUE
BVAXF
OUTLOOK RATING
1..100
241
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5585
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLUE's Valuation (21) in the Biotechnology industry is in the same range as BVAXF (42) in the null industry. This means that BLUE’s stock grew similarly to BVAXF’s over the last 12 months.

BLUE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BVAXF (100) in the null industry. This means that BLUE’s stock grew similarly to BVAXF’s over the last 12 months.

BLUE's SMR Rating (100) in the Biotechnology industry is in the same range as BVAXF (100) in the null industry. This means that BLUE’s stock grew similarly to BVAXF’s over the last 12 months.

BLUE's Price Growth Rating (55) in the Biotechnology industry is in the same range as BVAXF (85) in the null industry. This means that BLUE’s stock grew similarly to BVAXF’s over the last 12 months.

BLUE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BVAXF (100) in the null industry. This means that BLUE’s stock grew similarly to BVAXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLUE
RSI
ODDS (%)
Bullish Trend 13 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
88%
Momentum
ODDS (%)
Bullish Trend 13 days ago
79%
MACD
ODDS (%)
Bullish Trend 13 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
79%
Advances
ODDS (%)
Bullish Trend 27 days ago
77%
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
Aroon
ODDS (%)
Bearish Trend 13 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLUE has been loosely correlated with ARGX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if BLUE jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLUE
1D Price
Change %
BLUE100%
-0.40%
ARGX - BLUE
40%
Loosely correlated
-0.61%
MTVA - BLUE
37%
Loosely correlated
-5.08%
CYCN - BLUE
35%
Loosely correlated
-5.78%
CTMX - BLUE
33%
Loosely correlated
+12.94%
MNKD - BLUE
31%
Poorly correlated
-3.21%
More

BVAXF and

Correlation & Price change

A.I.dvisor tells us that BVAXF and BLUE have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and BLUE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVAXF
1D Price
Change %
BVAXF100%
+9.15%
BLUE - BVAXF
27%
Poorly correlated
-0.40%
APLM - BVAXF
27%
Poorly correlated
+1.14%
RVMD - BVAXF
25%
Poorly correlated
+2.04%
SPHDF - BVAXF
25%
Poorly correlated
-7.23%
WVE - BVAXF
23%
Poorly correlated
+1.85%
More